Neurological

A robust new study has comprehensively demonstrated how SARS-CoV-2, the coronavirus that causes COVID-19, can infect the brain and central nervous system. The study validates a growing body of research attributing neurological issues to COVID-19.

Scientists studying the mechanisms behind cellular stress and its effects on aging have found success in reversing cognitive decline in mice using an experimental drug, which bodes well for further study of aging and its effects in human subjects.

Research has suggested that anxiety is an early indicator for Alzheimer's disease, which often follows mild cognitive decline (MCI). A new study has now found a link between anxiety and an increased rate of progression from MCI to Alzheimer's disease.

A UK team has demonstrated a novel technology for imaging the brains of infants and babies. The breakthrough is hoped to allow researchers new ways to investigate baby brain activity in natural environments without the need for expensive MRI machines.

New research has shown how immune cells produced in the gut play a protective role during MS flare-ups. For the first time scientists have shown how these immune cells travel up to the brain and potentially help shift a disease flare-up into remission.

An exploratory study has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks. The preliminary trial was small but the promising findings suggest potential for psychedelics to treat migraines.

A new study is presenting a robust hypothesis to explain how a parasitic infection can alter behavior. The research provides new insights into how neurophysiological changes influence behavior, and points to novel therapeutic research targets.

A new study, published in the journal Chaos, is suggesting tracking changes over time in the way multiple sclerosis (MS) patients type on their smartphone touchscreens could be a useful method to monitor neurological degeneration.

When someone has experienced a stroke or brain injury, it's not uncommon for them to lose their ability to swallow. A new study, however, suggests that a throat-zapping system could help correct the problem faster than traditional treatments.

A new analysis of US patient data has found nearly one in five people are diagnosed with a psychiatric illness within three months of a positive COVID-19 test. The study suggests recovered patients are twice as likely to suffer from anxiety or depression.

New research is showing how the psychedelic drug DMT can promote brain plasticity and induce formation of new neurons. The study presents evidence to suggest the hallucinogenic effects of the drug could be divorced from this neuron-generating mechanism.

For years research has detected a correlation between depression and risk of stroke. A new study is offering more evidence of the link, presenting data from a research project investigating whether race factors into the depression/stroke relationship.